Objectives: To examine access and equity to induced abortion services in Australia, including factors associated with presenting beyond nine weeks gestation.
T he safety and efficacy of the combined mifepristone and misoprostol regimen for medically induced abortion has been well established. [1] [2] [3] In Australia, however, despite the availability of surgically induced abortion, a long history of legal and policy restrictions on the import of mifepristone prevented expansion of medical provision until 2012. 4, 5 That year MS Health, a subsidiary of Marie Stopes International, received approval from the Therapeutic Goods Administration to import, register and distribute mifepristone for a medical abortion up to 49 days gestation, and to register and train clinicians in service delivery. 6 Subsequently, the medicines were subsidised on the Pharmaceutical Benefits Scheme (PBS) for $38.30, 7 and indication for use extended up to nine weeks (63 days). 8 As a suitable alternative to surgery, 1 a medical abortion can be effectively provided in primary care settings with appropriate followup and emergency arrangements, 9 enabling service expansion. This can potentially improve access and reduce travel costs, particularly for women in rural and regional areas. The treatment can be taken earlier in pregnancy, and women can safely undergo the abortion at home, and experience it more naturally as a miscarriage, 10 options that women value and find acceptable. 11 Recent data from England, Wales and France indicate that amongst women eligible for both options, a majority chose medical, 12, 13 and in the United States, this proportion is steadily increasing. 14 In Australia, the number of certified prescribers and pharmacy dispensers is growing, including in non-metropolitan areas. 15 However, fundamental issues around access remain. Public service provision is very limited and poorly coordinated, and when available, restricted to a few facilities located in major cities. Most women rely on fee-charging private providers, and while Medicare (Australian public health insurance) holders can access a rebate, they still incur out-of-pocket costs. Service provision is also severely hampered by varying restrictive state and territory abortion legislation, which in certain jurisdictions, is not in line with current medical evidence and/or standards. 16 In the Northern Territory, for instance, the medical option is not currently offered, as the law permits abortions only within hospitals, preventing general practitioners from offering medical abortions within their community-based practices. Women who were ≥16 years, presenting for an abortion on the day, judged able to provide informed consent by trained administrative recruiting staff and with sufficient English proficiency were eligible to participate. Clinic administrative staff were trained to determine eligibility and invite clients to self-complete a brief paper-based anonymous questionnaire in the waiting room, prior to their clinical consultation and payment of treatment/procedure costs. Consent was implied if a client returned a questionnaire.
Clinic staff posted completed questionnaires on a weekly basis to the project coordinator. Each survey was linked to a clinic by a specific code. Double data entry was conducted by a specialist external data entry company. The study was approved by the La Trobe University Human Ethics Committee (14-073).
Measures
Data were obtained via self-report. We collected socio-demographic data on birth year and country, Aboriginal and/or Torres Strait islander origin, and postcode and suburb. We recoded postcode data into the Australian Statistical Geographical Standard measure of remoteness (major cities, inner regional, outer regional and remote/very remote). 20 Respondents reported whether they were currently studying (yes/no), employed (no, full-time, part-time, casual) and their current relationship status (married, living with partner, in a relationship, single, divorced/separated, widowed). We used the respondent's highest educational qualification (≤ year 10, year 12, trade certificate, graduate/post graduate) and receipt of a pension/government benefit as primary income (yes/no) as proxies for socioeconomic status.
Analyses
We fitted bivariate logistic regression models accounting for clinic clustering to determine unadjusted associations between hypothesised predictor variables and the outcome of presentation later than nine weeks. In the adjusted model, we included variables associated with later presentation at p≤0.20 level. Adjusted odds ratios and 95% confidence intervals derived from multiple logistic regression were used to determine factors associated with presenting later than nine weeks. Certain non-significant variables (p>0.05) such as geographic location were retained in the final model since its inclusion was considered important from a conceptual standpoint.
Using the limited data available on age and abortion method for the general Dr Marie client population, we compared differences in age group and method proportions between respondents and non-respondents and across clinics. All statistical analyses were conducted using STATA® version 13.0.
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Results
Of the 9,903 eligible women, 2,326 (23.5%) responded to the survey. Women who chose a medical abortion were slightly overrepresented in our sample (29.3%), compared to the overall client population (25.5%). Amongst medical abortion clients, there were no significant differences in response rates across age groups. Among surgical clients, the response rates of women aged 35-39 was slightly lower than those in other age groups.
The variation in response rates across clinics was significant (p<0.05), ranging from 8.1% to 63.8% for surgical, and 10.3% to 87.1% for the medical group.
Participant characteristics
On average, respondents were 28 years old ( The two equally common reasons were that it required only one clinic visit and that is was a comparatively faster process (63.0%). Women also felt that there were lower risks of heavy and prolonged bleeding (44.1%).
Major challenges faced
Six of every ten (61.1%) women who responded to the question on challenges experienced in obtaining an abortion reported at least one challenge. Of this group, nearly a quarter (23.0%) reported having trouble deciding whether to undergo an abortion, 13.1% reported being unaware of the pregnancy for a long time, and one in 10 didn't know where to go.
Travel and costs
Around two-thirds of women (62.6%) travelled less than an hour to get to the clinic, however more than one in 10 (11.2%) had an overnight stay. Overall, a greater proportion of women who lived outside major cities experienced longer travel times. About 4.0% had their abortion in a state outside their state of residence. 
*Total numbers vary across variables due to missing data p-values represent significance of difference between participants in abortion groups using Chi-square
Under 1% reported an abortion free of cost, and of this group, nearly half cited an external organisation as their source of financial assistance. An overwhelming majority had Medicare coverage (97.6%), however 5.0% did not use or were unsure about using it to subsidise costs. Among women who used Medicare, the reported median upfront cost of a medical abortion was $560, compared to $470 for a surgical abortion at ≤9 weeks, however the final out-of-pocket direct costs for the patient are the same. Without the Medicare rebate or PBS reimbursement for the cost of the medicine, the median costs for both medical and surgical abortions at ≤nine weeks roughly doubled.
As women progressed beyond the first trimester, the cost of the surgical procedure rose at key gestational intervals, whilst the value of the Medicare rebate remained constant. For women who used the rebate, the median out-of-pocket costs for surgical procedures at 13-19 weeks and beyond 19 weeks were three ($1,500) and 16 times ($7,700) greater than the median out-ofpocket costs within the first trimester ($470).
About 41% reported indirect costs related to travel and accommodation, GP referrals and medical tests, childcare and lost wages. The median cost for these additional expenses was $150.
Financial assistance and implications
Participants were asked about difficulties in financing the abortion in two separate questions. About 22.5% reported experiencing trouble with financial costs as a challenge in accessing the service. Separately, one in three (34.0%) women reported that they found it difficult/very difficult to pay for the abortion. Just over two-thirds of survey respondents (68.1%) obtained financial assistance from one or more sources to help pay for the abortion. The husband/partner/ man involved in the pregnancy was the most commonly cited source (80.0%) of help, followed by a family member (16.0%). About 64.0% answered the question on having to forego regular payments to cover abortion costs. Among them, just over a third (35.1%) had to forego one or more payments, most often for bills (71.2%), followed by food and groceries (35.5%).
Factors associated with later presentation
About 16.0% of respondents were undergoing an abortion after 9 weeks, and therefore no longer eligible for the medical option. In a multivariate model (Table  2 ) adjusted for age, country of birth and educational status, we found that women who had to travel four or more hours (OR: 3.0, 95%CI 1.2-7.3), who had no knowledge of the medical option (OR: 2.1, 95%CI 1.4-3.1), and who experienced difficulties in financing the abortion (OR: 1.5, 95%CI 1.2-1.9) had significantly higher odds of presenting later than nine weeks gestation. Also, women who identified as Aboriginal and/or Torres Strait Islander (OR: 2.1, 95%CI 1.2-3.4) and who received a government pension as main income (OR: 1.5, 95%CI 1.0-2.1) had higher odds of later presentation.
Discussion
For women terminating early pregnancies in Australia, the option of a medical abortion has become more readily available in most states and territories. This study found that 84% of our sample was within the gestational age limit for a medical abortion, indicating that they could detect a pregnancy early, and then obtain rapid access to an abortion clinic. Among women attending within nine weeks gestation, a minority (35%) chose a medical abortion. Since women having medical abortions were over-represented in our sample overall, this is a slight over-estimate.
We hypothesise several reasons why fewer eligible women chose the medical option. First, clients undergoing a medical treatment have to return after a fortnight for a clinical assessment to exclude a continuing pregnancy. This final step may serve as a deterrent. A growing body of international literature 22, 23 comparing self-assessment versus clinical follow-up after a medical abortion suggests that self-assessment is as effective. Second, the subsidised price of the composite pill pack was anticipated to substantially reduce the cost of a medical abortion, making it a more affordable option. We found that for women who intended to use the Medicare rebate, the median upfront cost of a medical treatment was in fact higher than a surgical procedure. However, women choosing the medical treatment could subsequently claim back between $60-$90 for the consultation and ultrasound, making the out-of-pocket costs for medical and surgical options roughly on par. Third, compared to countries such as England and France, where medical abortion has been available for much longer, and is the preferred option, it has only been a few years since it has become more widely available in Australia. Additional time is needed for further expansion of services, and for women to become knowledgeable about this option and feel comfortable choosing it for themselves.
Our sample had nearly universal Medicare coverage, and most women used the Medicare rebate to subsidise their abortion. A smaller proportion of our sample (7.5%) either did not have Medicare or didn't use the rebate compared to reports from earlier studies in Victoria (13.1%) in 2004 24 and New South Wales (15.1%) in 1998. 25 The Medicare subsidy, which reduced a first trimester abortion cost by half, is likely to play a critical role in improving access, particularly For one in three women, financial costs were not limited to the treatment/procedure alone, but included additional related expenses incurred. More than one in five women reported concern about meeting the costs of an abortion. A higher proportion (34.0%) expressed difficulty in actually paying for it along the way. More than two-thirds of our sample relied on financial assistance from others, and a minority delayed paying regular household expenses to compensate for the costs associated with undergoing an abortion. Taken together, these findings demonstrate the extent of financial burden that women undergo to obtain their abortion.
Women who had to travel four or more hours, who had no knowledge of the medical option prior to their decision, and who reported difficulty paying had significantly higher odds of presenting later than nine weeks, as did women who received a government pension as main income and identified as Aboriginal and/or Torres Strait Islander. These results indicate that the potential for medical abortion to improve equitable access to abortion services will remain limited unless knowledge, financial and geographical barriers to obtaining early care are adequately addressed. Since these data were collected, the option of a medical abortion via telemedicine has become available from MSI 28 and Tabbot Foundation, 29 another independent organisation. While women, particularly those residing in rural and remote areas will benefit from less travel, and be able to better protect their privacy, whether provision by telemedicine substantially reduces out-of-pocket costs for women remains to be determined. Internationally, there is increasing recognition that trained mid-level providers such as nurses or midwives can provide safe and effective abortion care, 9 and if introduced in the Australian context, may help in reducing costs and expanding services.
We acknowledge important limitations to our study. This survey was administered amongst English-proficient women at private Dr Marie clinics, and findings are not necessarily representative of the wider population of women obtaining abortions in Australia. Yet about one-third of abortions in the country are conducted in these clinics 15 and therefore they provide a useful starting point to assess costs and the equitability of access. The low response rate and its variability across clinics necessitate that findings be interpreted with caution. The sensitivity of the topic and the vulnerability that many women experience in the waiting room of an abortion clinic is likely to have precluded better participation. As a self-administered survey, we had to contend with considerable missing data for certain variables. For instance, we were unable to assess the role of private health insurance in payment for abortion because more than a third did not report whether they possessed private insurance, and substantially fewer responded to questions about coverage for their abortion service provision. The overwhelming lack of response to these questions may be indicative of women's own uncertainties around whether they are privately insured and if and how they can use private coverage to subsidise abortion costs.
Despite these limitations, our findings have important implications. Almost one in four (23%) had difficulty making the decision about whether to undergo an abortion. Previous research on reasons for having an abortion have consistently indicated that women make this decision taking into account a diverse and complex array of personal, familial and social factors. 30 We also found that undergoing an abortion, at any gestation, requires significant upfront and out-of-pocket expenditure, and poses a financial burden to many women. Increasing the Medicare rebates will lower the burden, particularly for women having abortions beyond the first trimester, who are more likely to be disadvantaged. Policy initiatives to improve availability and access to medical abortion have improved choice for some women, however abortion costs remain expensive. Like women in many developed countries, 31 Australian women who are socially, geographically and economically disadvantaged, have limited choice and access to abortion.
Conclusions and implications
Future research evaluating the impact of telemedicine in promoting early and affordable abortion access will build on these findings. Policymakers should investigate (a) how to prevent more unwanted pregnancies and (b) how to overcome the barriers outlined in this study and increase the rates of women accessing services at an early gestational age, which would save both women and the overall health system greater financial and health burdens.
